Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Simulations Plus Inc (SLP)

Simulations Plus Inc (SLP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 932,300
  • Shares Outstanding, K 19,985
  • Annual Sales, $ 59,580 K
  • Annual Income, $ 9,960 K
  • 60-Month Beta 0.72
  • Price/Sales 15.43
  • Price/Cash Flow 54.33
  • Price/Book 5.08
Trade SLP with:

Options Overview Details

View History
  • Implied Volatility 40.02% ( -8.78%)
  • Historical Volatility 71.75%
  • IV Percentile 43%
  • IV Rank 60.87%
  • IV High 63.83% on 02/14/24
  • IV Low 2.98% on 05/08/23
  • Put/Call Vol Ratio 999.99
  • Today's Volume 2
  • Volume Avg (30-Day) 143
  • Put/Call OI Ratio 0.25
  • Today's Open Interest 381
  • Open Int (30-Day) 778

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 05/31/24
See More
  • Average Estimate 0.18
  • Number of Estimates 1
  • High Estimate 0.18
  • Low Estimate 0.18
  • Prior Year 0.20
  • Growth Rate Est. (year over year) -10.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
37.75 +19.67%
on 04/03/24
51.00 -11.42%
on 04/09/24
+3.56 (+8.54%)
since 03/25/24
3-Month
35.98 +25.56%
on 02/05/24
51.00 -11.42%
on 04/09/24
+6.03 (+15.42%)
since 01/25/24
52-Week
32.69 +38.19%
on 10/27/23
52.69 -14.26%
on 08/08/23
+2.27 (+5.30%)
since 04/25/23

Most Recent Stories

More News
Simulations Plus: Fiscal Q2 Earnings Snapshot

Simulations Plus: Fiscal Q2 Earnings Snapshot

SLP : 45.38 (-2.72%)
Simulations Plus: Fiscal Q1 Earnings Snapshot

Simulations Plus: Fiscal Q1 Earnings Snapshot

SLP : 45.38 (-2.72%)
Simulations Plus: Fiscal Q4 Earnings Snapshot

Simulations Plus: Fiscal Q4 Earnings Snapshot

SLP : 45.38 (-2.72%)
Simulations Plus: Fiscal Q3 Earnings Snapshot

Simulations Plus: Fiscal Q3 Earnings Snapshot

SLP : 45.38 (-2.72%)
Happy National Holidays

Monday U.S. Economic Lookahead ISM Manufacturing (June) Construction Spending ...

CULP : 4.60 (+0.66%)
SLP : 45.38 (-2.72%)
NUMI.TO : 0.0800 (unch)
RCH.TO : 38.69 (-0.85%)
ATZ.TO : 33.05 (-2.54%)
The Zacks Analyst Blog Highlights Atlassian, Zscaler, Simulations Plus and Asure Software

Atlassian, Zscaler, Simulations Plus and Asure Software are part of the Zacks top Analyst Blog.

SLP : 45.38 (-2.72%)
ASUR : 7.07 (-1.81%)
TEAM : 197.43 (-0.79%)
ZS : 174.05 (-1.92%)
4 Low-Beta Tech Stocks to Hedge Against Market Uncertainty

Investors can consider adding four low-beta tech stocks like TEAM, ZS, SLP and ASUR in their portfolios to hedge against a highly-volatile market.

SLP : 45.38 (-2.72%)
ASUR : 7.07 (-1.81%)
TEAM : 197.43 (-0.79%)
ZS : 174.05 (-1.92%)
Simulations Plus Receives U.S. FDA Renewal for DILIsym Software Licenses

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that the U.S. FDA has renewed its licenses...

SLP : 45.38 (-2.72%)
Can Simulations Plus (SLP) Climb 53.66% to Reach the Level Wall Street Analysts Expect?

The mean of analysts' price targets for Simulations Plus (SLP) points to a 53.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts...

SLP : 45.38 (-2.72%)
Simulations Plus (SLP) Q2 Earnings Beat, Revenues Up Y/Y

Simulations Plus' (SLP) Q2 results are driven by higher revenues in Software and Services business segments.

SLP : 45.38 (-2.72%)
PERI : 11.67 (-1.52%)
PEGA : 57.22 (-2.82%)
ANET : 262.87 (+3.18%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab,...

See More

Key Turning Points

3rd Resistance Point 48.10
2nd Resistance Point 47.48
1st Resistance Point 47.06
Last Price 45.38
1st Support Level 46.02
2nd Support Level 45.40
3rd Support Level 44.98

See More

52-Week High 52.69
Last Price 45.38
Fibonacci 61.8% 45.05
Fibonacci 50% 42.69
Fibonacci 38.2% 40.33
52-Week Low 32.69

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar